AMLN, Green Light from FDA to Its BYETTA for Expanded Use as First-Line Treatment for Type 2 Diabetes. AMLN, X-Treme Hot Stock Alert by DrStockPick.com
CRWENEWSWIRE's DrStockPick.com is pleased to announce its X-Treme Hot Stock Alert
Las Vegas, NV 10/31/2009 05:25 PM GMT (TransWorldNews)
***FREE Stock Alerts*** From CRWENEWSWIRE's DrStockPick.com
Click on the link Below:
http://www.crwenewswire.com/c/drstockpick________________________________________________________
AMLN, Amylin Pharmaceuticals, Inc.
AMLN is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development and commercialization of innovative medicines.
AMLN has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and BYETTA® (exenatide) injection.
The U.S. Food and Drug Administration (FDA) has approved an expanded indication for AMLN's BYETTA® (exenatide) injection. BYETTA is now approved for use as a stand-alone medication (monotherapy) along with diet and exercise to improve glycemic control in adults with type 2 diabetes. Previously, it was approved for use only in patients who were also taking other common diabetes medications and had not achieved adequate glycemic control.
AMLN's BYETTA has been used by more than one million patients since market introduction in 2005. It has a proven history with more than 10 million prescriptions written and 6.5 years of clinical experience.
About DrStockPick.com
DrStockPick.com is a stock watch website, a CRWENewsWire.com Division that provides free daily alerts on stocks. DrStockPick.com's alerts are daily e-mail on stocks that are hot in the market. These include stocks with huge volume, penny stocks, stocks with technical indicators and much more. DrStockPick.com also tracks small cap stocks that are on the brink of moving upwards. DrStockPick.com also features companies on its website with research report, analysis, and newsletters.
DrStockPick.com is an independent electronic publication that provides information on selected publicly traded companies. DrStockPick.com is not a registered investment advisor or broker-dealer.
We encourage investors to join the FREE e-mail alerts by visiting:
http://www.crwenewswire.com/c/drstockpick
About CRWENewswire.com
CRWENewswire.com is an independent electronic informative online financial news publication company dedicated in providing company associates, business and financial professionals with economic and investment information, as well as stock highlights. CRWENewswire.com is a division of Crown Equity Holdings, Inc.
***FREE STOCK ALERTS**
Sign up to receive FREE stock alerts from CRWENewswire's DrStockPick.com at
http://www.crwenewswire.com/c/drstockpick
Forward Looking Statement
This press release contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. With the exception of historical information contained herein, the matters discussed in this press release involve risk and uncertainties. Actual results could differ materially from those expressed in any forward-looking statement.
info@drstockpick.com
www.crwenewswire.com/c/drstockpick
Email Article to a friend
|
View Profile
Visit Blogs
|
NEWS ALERTS
Receive alerts for
AMLN
to your inbox.
Sign up for TransWorldNews Alerts
TransWorldNews, Inc. and its affiliate sites disclaim all liability for information and content provided by clients and appearing within their news and press releases.
